Ameriprise
CMTA

Ameriprise’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Ameriprise’s Portfolio CMTA Stock Details CMTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-153,742
Closed -$4.01M – 3850
2019
Q1 		$4.01M Buy
153,742
+78,008
+103% +$1.46M ﹤0.01% 2364
2018
Q4 		$891K Buy
+75,734
New +$942K ﹤0.01% 2985

Ameriprise's CMTA Position: Q2 2019 in Review

Ameriprise sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q2 2019, closing a stake of 153,742 shares — an estimated $4.01M sold.

Ameriprise first reported a position in CMTA in Q4 2018 and held it in 2 quarters. The position peaked at $4.01M in Q1 2019. 0 funds tracked by Wall St. Rank hold CMTA as of Q2 2019.

  • Ameriprise reported no remaining Clementia Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
  • Ameriprise sold 153,742 Clementia Pharmaceuticals Inc. shares in Q2 2019, an estimated $4.01M.
  • Ameriprise first reported a position in Clementia Pharmaceuticals Inc. in Q4 2018 and held it in 2 quarters.
  • Ameriprise's Clementia Pharmaceuticals Inc. position peaked at $4.01M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q2 2019.

Based on Ameriprise's 13F filing for Q2 2019, filed 14 Aug 2019.